SOURCE: Bellwether Report

May 10, 2005 12:59 ET

BWR Evaluates Nasdaq Top Gainers NUAN, GEMS, SYKE and IMCL

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report.

TORONTO -- (MARKET WIRE) -- May 10, 2005 -- The Bellwether Report is the leading online financial newsletter, focusing on small-cap emerging growth opportunities. We strive to introduce investors to truly undervalued opportunities in a time friendly fashion, allowing for optimal entry points and profitable exit points. Today, BWR will be evaluating the day's four most promising companies on the Nasdaq Exchange, Nuance Communications (NASDAQ: NUAN), Glenayre Technologies (NASDAQ: GEMS), Sykes Enterprises (NASDAQ: SYKE) and once again Imclone Systems (NASDAQ: IMCL). For more information on the BWR or any of the above mentioned companies feel free to visit for a free no obligation 30 day trial of our service.

Nuance Communications, a developer and marketer of speech software products, is trading up 41% today after their rival Scansoft Inc agreed to purchase the company for $221 million. Shares of Nuance Communications, had come off quite heavily over the past 6 months, however with this new development shares of Nuance are valued $5.63, $.33 above their previous 52 week high.

Small-cap gem, Glenayre Technologies is trading up another 11% today, the company announced yesterday that it would buy Universal Music Group's North American and central European CD and DVD manufacturing and distribution operations for about $122 million. Investors are feeling that this is a great move for Glenayre, as the company traded up 22% yesterday as well. BWR will be aggressively tracking GEMS and the progress that we feel they will make over the ensuing months.

Sykes Enterprises is trading just off their 52 week high of $8.50. This global leader in providing outsourced customer contact management solutions and services in the business process outsourcing (BPO) arena announced yesterday financial results for the first quarter of 2005. The company made significant improvements in key areas. BWR will be evaluating their growth over the next 3 months to see if they are able to continue to break through new barriers.

ImClone Systems, a BWR regular, may finally be poised for the turnaround they so long await. After a terrible 10 months, where the company lost over 60% of their value, ImClone has bounced, trading up $1.62. Although it may seem meager, and only a small step in regaining the ground lost, it's a bright spot for the biopharmaceutical company.

For 30 days complimentary with the BWR service feel free to visit and sign up. No credit card needed!!

The Bellwether Report to date has not been compensated by any of the above-mentioned companies.

Contact Information